Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancerYusuke Inoue, Haruhiko Sugimura|Oncotarget|2017Cited by 173
Evaluation of Programmed Death Ligand 1 (<i>PD-L1</i>) Gene Amplification and Response to Nivolumab Monotherapy in Non–small Cell Lung CancerYusuke Inoue, Takafumi Suda|JAMA Network Open|2020Cited by 35
Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapyYusuke Inoue, Takafumi Suda|Cancer Immunology Immunotherapy|2023Cited by 14